Development of High-content Assays for Compound Screening and Hit Validation

In this presentation, Dr. Kamyar Hadian (head of the #assay development and Screening Platform’ at the HelmholtzZentrum München in Munich/Germany) talk about #hcs use in #stem cell– and microtissue-based assays. #phenotypic screening has highly emerged in the past years. Especially High-Content Screening (HCS) has gained strong acceptance in the field Read more…

New Content Screening Platform for Cancer Applications

“A new high-content screening software platform enables cancer researchers to uncover more about basic and advanced cellular function to accelerate cell-based research. The Thermo Scientific HCS Studio 2.0 is a high-content quantitative imaging and analysis software platform for a range of cancer research applications, including angiogenesis and migration/invasion, as well Read more…

New application for HCS

Non-invasive cancer- diagnosis: a new application for HCS HCS was first used in pharmaceutical industry to develop a new way to find new drugs. But this technology is extended since few years in other domains, as diagnosis! source: http://www.int.laborundmore.de/news/694729/A-new-application-for-microscopy.html